Shineco (SISI) Stock Analysis & Winston Score
Shineco, Inc. is a small Chinese company that sells health and wellness products, including herbal medicines, traditional Chinese medicine (TCM) ingredients, and agricultural products like organic teas and plant-based goods. Its customers are mainly consumers and distributors in China who buy these products for everyday health purposes. The company operates in the specialty and generic drug space but also spans agriculture and natural health products. Shineco makes money by selling these physical goods directly to buyers, with very thin profit margins — its gross margin is only about 3.5%, meaning it keeps very little from each sale. The company is based in China and is quite small, with essentially no measurable market cap, which signals serious financial strain. Its operating margin of roughly negative 207% means it is spending far more than it earns, and the key risk facing Shineco is whether it can cut costs and grow revenue fast enough to survive as a going concern.
Winston Score: 21/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.25
Market Cap: $0M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
